Olivier Vitse

Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease

Mazen M. Dimachkie, Richard J. Barohn, Barry J. Byrne et al. · Neurology · 2022 · 42 citations · Full text

New imidazo[1,2-a]pyrazine derivatives with bronchodilatory and cyclic nucleotide phosphodiesterase inhibitory activities

Olivier Vitse, Florence Laurent, Tristan Pocock et al. · Bioorganic & Medicinal Chemistry · 1999 · 28 citations

Biochemistry, Medicine, Natural Sciences +8

First‐in‐human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple oral doses of SAR247799, a selective G‐protein‐biased sphingosine‐1 phosphate receptor‐1 agonist for endothelial protection

L. Bergougnan, Sara Armani, Georg Golor et al. · British Journal of Clinical Pharmacology · 2020 · 14 citations · Full text

Endothelial‐protective effects of a G‐protein‐biased sphingosine‐1 phosphate receptor‐1 agonist, SAR247799, in type‐2 diabetes rats and a randomized placebo‐controlled patient trial

L. Bergougnan, Grit Andersen, Leona Plum‐Mörschel et al. · British Journal of Clinical Pharmacology · 2020 · 13 citations · Full text

Aza-indolizine with bridgehead nitrogen. Metalation, halogen-metal exchange and directed ortho-lithiation in the imidazo[1,2-a]pyrazine series

Olivier Vitse, Jacques Bompart, Guy Subra et al. · Tetrahedron · 1998 · 11 citations

Chemical Engineering, Engineering, Heterocyclic +5